HUMAN monocytes, preincubated with IFN-% respond to IL-4 by a cGMP increase through activation of an inducible NO synthase. Here, was found to induce an accumulation of cGMP (1-rain) and cAMP (20-25 min) 
Introduction
Interleukin-4 (IL-4) is a 20kDa glycoprotein, produced by activated T lymphocytes (Th2), mast cells, basophils and other cell types, which displays a broad spectrum of biological activity on haematopoietic cells. On monocytes/macrophages, IL-4 enhances the expression of MHC class II antigens, adhesion molecules of the (leucocyte functional antigen) family 2 and CD23. In contrast, IL-4 down-regulates the expression of Fc3,RI (CD64) and Fc3,RII (CD32) and inhibits the induction of Fc3tRIII (CD16) by IFN-3t 4 or TGF- [3. 5 IL-4 also down-regulates the expression of CD14 on monocytes. 6 IL-4 acts as an antiinflammatory mediator by decreasing the release of IL-1, TNF-a, IL-6, IL-8 and prostaglandin E2 by human monocytes and by reducing their capacity to produce reactive oxygen species. [7] [8] [9] [10] [11] [12] IL-4 also induces the secretion of G-and M-CSF by monocytes 3 and triggers their differentiation into macrophage-like cells type in vitro.
The binding component of the IL-4 receptor belongs to the family of haemapoietin receptors 14a5 and is associated, at least in some cell types, to the y chain previously reported for the 16 22 IL-2 receptor.
The importance of protein tyrosine phospholation in IL-4 signalling is now 23 28 29
well recognized and recently, the Jak-3 and 0 Lsk 3 have been identified as the major tyrosine kinases involved. Several transcription factors are selectively activated through IL-4-induced tyrosine phosphorylation. 3 '2 We recently described that IL-4 induced an accumulation of cGMP in monocytes of certain donors, which was greatly enhanced by preincubation with IFN-3t and was dependent on the t-arginine-dependent pathway of nitric oxide synthase (NOS) activation, since it was markedly reduced in the presence of NOS inhibitors. 33 We also reported that IL-4 displayed a biphasic effect on the capacity of cultured monocytes to release nitrite in their supernatants. 4 in the present work, we have further analysed the effect of It-4 on the production by monocytic cells of the cyclic nucleotides cAMP and cGMP.
Materials and Methods
Reagents: Recombinant human IL-4 obtained from Escherichia coli (specific activity, 1 x 107U/ mg, 1 U 1 ng) was purchased from Immugenex (Los Angeles, CA, USA). Isobutyl methyl xanthine (IBMX), EGTA (ethylene glycol-bis( [3-aminoethy- lether) N,N,N',N'-tetraacetic acid) and the two inhibitors of calmodulin, calmidazolium and W-7, were purchased from Sigma (Saint Louis, MO, USA). A-mono-methyl-t-arginine (t-NMMA) and A-nitro-I.-arginine (t-NA), two N-guanido-substituted analogues of t-arginine, competitive inhibitors of NO 4 In the present work, we show that IL-4 induces cAMP and cGMP generation in unstimulated human monocytes. A rather large heterogeneity in the response of the different individuals was observed, which may be explained by the fact that, except for the absence of HIV or hepatitis infection and of allergy, the immunological status of these donors was largely unknown. One cannot exclude the possibility that some of these volunteers were primed otherwise which may explain the variation in the response observed and the biphasic cAMP response which was detected for some of them. We 
